Free Trial

Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts

Pacific Biosciences of California logo
$1.66 -0.20 (-10.51%)
(As of 01:00 PM ET)

Pacific Biosciences of California Latest Earnings Summary

Upcoming Q3
Earnings Date
Feb. 20Estimated
Actual EPS
(Aug. 7)
-$0.20 Beat By $0.04
Consensus EPS
(Aug. 7)
-$0.24

Pacific Biosciences of California issued Q2 2024 earnings on August 7, 2024, reporting an EPS of -$0.20, which beat the consensus estimate of -$0.24 by $0.04. Quarterly revenue was reported to be $36.01 million, below analyst estimates of $40.52 million. With a trailing EPS of -$1.46, Pacific Biosciences of California's earnings are expected to grow next year, from ($0.90) to ($0.66) per share.

PACB Upcoming Earnings

Pacific Biosciences of California's next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules.

Get Pacific Biosciences of California Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacific Biosciences of California and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PACB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PACB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacific Biosciences of California Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.29-$0.29-$0.29
Q3 20241-$0.26-$0.26-$0.26
Q4 20241-$0.26-$0.26-$0.26
20243-$0.81-$0.81-$0.81
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.22-$0.22-$0.22

Pacific Biosciences of California Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/20/2025
(Estimated)
------- 
8/7/2024Q2 2024-$0.24-$0.20+$0.04$0.24$40.52M$36.01M
5/9/2024Q1 2024-$0.26-$0.26--$0.23$38.78M$38.81M    
2/15/2024Q4 2023-$0.29-$0.27+$0.02-$0.23$57.96M$58.36M      
10/30/2023Q3 2023-$0.29-$0.27+$0.02-$0.28$48.76M$55.70M      
8/2/2023Q2 2023-$0.32-$0.26+$0.06-$0.24$40.12M$47.57M        
5/2/2023Q1 2023-$0.33-$0.31+$0.02-$0.26$34.38M$38.90M        
2/16/2023Q4 2022-$0.34-$0.35 -$0.01-$0.33$27.29M$27.35M      

Pacific Biosciences of California Earnings - Frequently Asked Questions

Pacific Biosciences of California has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on PACB's earnings history.

In the previous quarter, Pacific Biosciences of California (NASDAQ:PACB) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.24) by $0.04. Learn more on analysts' earnings estimate vs. PACB's actual earnings.

Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $200.52 million.

Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$306.73 million. PACB has generated -$1.46 earnings per share over the last four quarters.

Pacific Biosciences of California's earnings are expected to grow from ($0.90) per share to ($0.66) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:PACB) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners